Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: January 27, 2023

Pliva Lachema Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for PLIVA LACHEMA, and what generic and branded alternatives to PLIVA LACHEMA drugs are available?

PLIVA LACHEMA has three approved drugs.

There is one tentative approval on PLIVA LACHEMA drugs.

Summary for Pliva Lachema

US Patents:	0
Tradenames:	3
Ingredients:	3
NDAs:	3

Drugs and US Patents for Pliva Lachema

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pliva Lachema	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	078631-003	Dec 2, 2008		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Pliva Lachema	IRINOTECAN HYDROCHLORIDE	irinotecan hydrochloride	INJECTABLE;INJECTION	078122-002	Oct 31, 2008		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Pliva Lachema	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	078631-001	Dec 2, 2008		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Pliva Lachema	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	078631-004	Dec 2, 2008		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Pliva Lachema	IRINOTECAN HYDROCHLORIDE	irinotecan hydrochloride	INJECTABLE;INJECTION	078122-001	Oct 31, 2008		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Pliva Lachema	PACLITAXEL	paclitaxel	INJECTABLE;INJECTION	077413-001	Mar 12, 2008		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Pliva Lachema	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	078631-002	Dec 2, 2008		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Merck

McKinsey

Mallinckrodt

Baxter

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.